RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Innoviva Stock

Innoviva Revenue 2024

Innoviva Revenue

345.38 M USD

Ticker

INVA

ISIN

US45781M1018

WKN

A2AC9U

In 2024, Innoviva's sales reached 345.38 M USD, a 11.25% difference from the 310.46 M USD sales recorded in the previous year.

The Innoviva Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e563.6547,52
2028e459.8258,25
2027e377.670,93
2026e376.2571,18
2025e347.3577,10
2024e345.3877,54
2023310.4686,27
2022331.395,83
2021391.968,34
2020336.879,52
2019261102,61
2018261102,61
2017217.2123,31
2016133.6200,47
201553.9496,89
20148.43188,37
20134.55951,62
2012135.8197,22
201124.51093,16
201024.21106,71
200924.41097,64
200823.11159,41
2007221217,38
200619.61366,44
200512.12213,41
20048.93009,25

Innoviva Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Innoviva, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Innoviva from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Innoviva’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Innoviva. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Innoviva’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Innoviva’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Innoviva’s growth potential.

Innoviva Revenue, EBIT and net profit per share

DateInnoviva RevenueInnoviva EBITInnoviva Net Income
2029e563.65 M undefined0 undefined147.4 M undefined
2028e459.82 M undefined205.22 M undefined117.41 M undefined
2027e377.6 M undefined162.18 M undefined85.51 M undefined
2026e376.25 M undefined148.25 M undefined83.27 M undefined
2025e347.35 M undefined135.07 M undefined72.74 M undefined
2024e345.38 M undefined148.48 M undefined33.82 M undefined
2023310.46 M undefined113.89 M undefined179.72 M undefined
2022331.3 M undefined207 M undefined213.9 M undefined
2021391.9 M undefined375.1 M undefined265.9 M undefined
2020336.8 M undefined321.1 M undefined224.4 M undefined
2019261 M undefined246.4 M undefined157.3 M undefined
2018261 M undefined238.3 M undefined395.1 M undefined
2017217.2 M undefined183.6 M undefined134.1 M undefined
2016133.6 M undefined109 M undefined59.5 M undefined
201553.9 M undefined31.6 M undefined-18.8 M undefined
20148.4 M undefined-33.9 M undefined-168.5 M undefined
20134.5 M undefined-28.8 M undefined-170.7 M undefined
2012135.8 M undefined-13 M undefined-18.5 M undefined
201124.5 M undefined-109.7 M undefined-115.3 M undefined
201024.2 M undefined-78.3 M undefined-83.9 M undefined
200924.4 M undefined-80.3 M undefined-85.3 M undefined
200823.1 M undefined-87.8 M undefined-93.6 M undefined
200722 M undefined-168.6 M undefined-160 M undefined
200619.6 M undefined-179.2 M undefined-166 M undefined
200512.1 M undefined-149.6 M undefined-143.2 M undefined
20048.9 M undefined-106.4 M undefined-102.7 M undefined

Innoviva stock margins

The Innoviva margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Innoviva. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Innoviva.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Innoviva's sales revenue. A higher gross margin percentage indicates that the Innoviva retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Innoviva's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Innoviva's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Innoviva's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Innoviva. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Innoviva's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Innoviva Margin History

Innoviva Gross marginInnoviva Profit marginInnoviva EBIT marginInnoviva Profit margin
2029e86.27 %0 %26.15 %
2028e86.27 %44.63 %25.53 %
2027e86.27 %42.95 %22.64 %
2026e86.27 %39.4 %22.13 %
2025e86.27 %38.89 %20.94 %
2024e86.27 %42.99 %9.79 %
202386.27 %36.68 %57.89 %
202295.83 %62.48 %64.56 %
202186.27 %95.71 %67.85 %
202086.27 %95.34 %66.63 %
201986.27 %94.41 %60.27 %
201886.27 %91.3 %151.38 %
201786.27 %84.53 %61.74 %
201686.27 %81.59 %44.54 %
201586.27 %58.63 %-34.88 %
201486.27 %-403.57 %-2,005.95 %
201386.27 %-640 %-3,793.33 %
201286.27 %-9.57 %-13.62 %
201186.27 %-447.76 %-470.61 %
201086.27 %-323.55 %-346.69 %
200986.27 %-329.1 %-349.59 %
200886.27 %-380.09 %-405.19 %
200786.27 %-766.36 %-727.27 %
200686.27 %-914.29 %-846.94 %
200586.27 %-1,236.36 %-1,183.47 %
200486.27 %-1,195.51 %-1,153.93 %

Innoviva Aktienanalyse

What does Innoviva do?

Innoviva Inc - An innovative story Innoviva Inc is a US-based company specializing in the development and marketing of therapy and diagnostic products for respiratory diseases. The company was founded in 1996 under the name Theravance Inc and was renamed Innoviva Inc in 2016. The story of Innoviva Inc began with the goal of developing innovative therapies for chronic respiratory diseases. Over the years, the company expanded and diversified its product portfolio. Today, Innoviva Inc is a leading provider of products for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Business model of Innoviva Inc The business model of Innoviva Inc is based on the development of products for the treatment of respiratory diseases and collaboration with other pharmaceutical and biotech companies. The company licenses its products to partner companies, which distribute them in the market. This way, Innoviva Inc generates revenue from licensing fees and milestone payments. Divisions of Innoviva Inc Innoviva Inc is divided into three divisions: development, licensing, and financing. The development division is responsible for researching and developing new therapy and diagnostic products. The company works closely with other pharmaceutical and biotech companies in this regard. The licensing division is responsible for licensing products to partner companies. This includes negotiating license agreements and conducting clinical trials. The financing division of Innoviva Inc is responsible for raising external capital. This includes issuing bonds and seeking investment. Products of Innoviva Inc Innoviva Inc has a wide range of therapy and diagnostic products for respiratory diseases. These include: - RELVAR®/BREO® (Fluticasone furoate/Vilanterol) for the treatment of COPD and asthma - ANORO® (Umeclidinium bromide/Vilanterol) for the treatment of COPD - TRELEGY® (Fluticasone furoate/Umeclidinium bromide/Vilanterol) for the treatment of COPD These products have been developed by Innoviva Inc and are licensed to partner companies for distribution. Innoviva Inc is an innovative company specializing in the development and marketing of products for the treatment of respiratory diseases. The business model is based on the development of products and licensing them to partner companies. Innoviva Inc has a wide range of therapy and diagnostic products for respiratory diseases. Innoviva ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Innoviva's Sales Figures

The sales figures of Innoviva originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Innoviva’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Innoviva's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Innoviva’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Innoviva stock

How much revenue did Innoviva generate this year?

Innoviva has achieved a revenue of 345.38 M USD this year.

How much was the turnover of the company Innoviva compared to the previous year?

The revenue of Innoviva has increased by 11.25% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Innoviva?

The revenue of Innoviva is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Innoviva measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Innoviva so important for investors?

The revenue of Innoviva is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Innoviva pay?

Over the past 12 months, Innoviva paid a dividend of 0.75 USD . This corresponds to a dividend yield of about 3.89 %. For the coming 12 months, Innoviva is expected to pay a dividend of 0 USD.

What is the dividend yield of Innoviva?

The current dividend yield of Innoviva is 3.89 %.

When does Innoviva pay dividends?

Innoviva pays a quarterly dividend. This is distributed in the months of December, April, July, October.

How secure is the dividend of Innoviva?

Innoviva paid dividends every year for the past 0 years.

What is the dividend of Innoviva?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innoviva located?

Innoviva is assigned to the 'Health' sector.

Wann musste ich die Aktien von Innoviva kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innoviva from 9/30/2015 amounting to 0.25 USD, you needed to have the stock in your portfolio before the ex-date on 9/8/2015.

When did Innoviva pay the last dividend?

The last dividend was paid out on 9/30/2015.

What was the dividend of Innoviva in the year 2023?

In the year 2023, Innoviva distributed 0 USD as dividends.

In which currency does Innoviva pay out the dividend?

The dividends of Innoviva are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Innoviva stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Innoviva

Our stock analysis for Innoviva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innoviva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.